Walgreens Boots Alliance (NASDAQ:WBA) had its price target lifted by Loop Capital from $80.00 to $82.00 in a research note published on Friday morning, The Fly reports. Loop Capital currently has a buy rating on the pharmacy operator’s stock.
WBA has been the subject of several other research reports. Zacks Investment Research raised shares of Walgreens Boots Alliance from a hold rating to a buy rating and set a $81.00 price target for the company in a research report on Tuesday, September 25th. ValuEngine raised shares of Walgreens Boots Alliance from a strong sell rating to a sell rating in a research report on Friday, September 21st. Robert W. Baird lifted their price target on shares of Walgreens Boots Alliance from $64.00 to $69.00 and gave the company a neutral rating in a research report on Tuesday, September 11th. Cowen downgraded shares of Walgreens Boots Alliance from an outperform rating to a market perform rating and set a $104.00 price target for the company. in a research report on Monday, July 23rd. Finally, BidaskClub raised shares of Walgreens Boots Alliance from a hold rating to a buy rating in a research report on Wednesday, September 12th. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating, seven have issued a buy rating and two have given a strong buy rating to the company. Walgreens Boots Alliance has a consensus rating of Hold and a consensus target price of $77.56.
Shares of WBA stock traded up $2.60 during trading hours on Friday, hitting $73.50. 9,645,179 shares of the company were exchanged, compared to its average volume of 6,227,956. The company has a market cap of $72.35 billion, a price-to-earnings ratio of 14.41, a price-to-earnings-growth ratio of 1.11 and a beta of 1.04. Walgreens Boots Alliance has a fifty-two week low of $59.07 and a fifty-two week high of $80.68. The company has a quick ratio of 0.47, a current ratio of 0.93 and a debt-to-equity ratio of 0.44.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Thursday, August 2nd. The stock was sold at an average price of $65.99, for a total transaction of $180,548.64. Following the transaction, the director now directly owns 10,943 shares in the company, valued at approximately $722,128.57. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Ornella Barra acquired 1,700,000 shares of the company’s stock in a transaction on Monday, July 16th. The shares were bought at an average price of $65.15 per share, for a total transaction of $110,755,000.00. The disclosure for this purchase can be found here. 14.80% of the stock is currently owned by company insiders.
Large investors have recently modified their holdings of the business. BlueMountain Capital Management LLC bought a new stake in shares of Walgreens Boots Alliance during the 2nd quarter worth $103,000. CSat Investment Advisory L.P. bought a new stake in shares of Walgreens Boots Alliance during the 2nd quarter worth $104,000. Squar Milner Financial Services LLC bought a new stake in shares of Walgreens Boots Alliance during the 2nd quarter worth $106,000. Kaizen Advisory LLC raised its stake in shares of Walgreens Boots Alliance by 128.6% during the 2nd quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock worth $116,000 after purchasing an additional 1,083 shares during the period. Finally, Livingston Group Asset Management CO operating as Southport Capital Management bought a new stake in shares of Walgreens Boots Alliance during the 3rd quarter worth $154,000. Institutional investors and hedge funds own 61.92% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Featured Article: Trading Strategy Methods and Types
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.